Azacitidine for Injection, 100 mg

Hazard statements (CLP)

H302, H350

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Classification (GHS-US) Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions. Pharmaceutical Agent – Handling of this product in its final form presents minimal occupational exposure risk. Classification of the Substance or Mixture Classification (GHS-US) Comb. Dust Acute Tox. 4 (Oral) H302 Carc. 1B H350 Full text of H-phrases: see section 16

2.2 Label elements

GHS-US labeling

Signal word

GHS07 GHS08 : Danger

Hazard statements

Comb. Dust - May form combustible dust concentrations in air H302 - Harmful if swallowed H350 - May cause cancer

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P264 - Wash hands, forearms and exposed areas thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P280 - Wear protective clothing, protective gloves, eye protection. P301+P312 - If swallowed: Call a POISON CENTER if you feel unwell. P308+P313 - If exposed or concerned: Get medical advice/attention. P330 - Rinse mouth. P405 - Store locked up. P501 - Dispose of contents/container in accordance with local, regional, national, territorial, provincial, and international regulations.

Other hazards

Not available

Ingredient(s) with unknown acute toxicity

Not available

2.1 Classification of the substance or mixture

Classification (GHS-US) Comb. Dust Acute Tox. 4 (Oral) H302 Carc. 1B H350 Full text of H-phrases: see section 16